Logo do repositório
 
Publicação

Meningococcal serogroup Y emergence in Europe: Update 2011

dc.contributor.authorBröker, M.
dc.contributor.authorJacobsson, S.
dc.contributor.authorKuusi, M.
dc.contributor.authorPace, D.
dc.contributor.authorSimões, Maria João
dc.contributor.authorSkoczynska, A.
dc.contributor.authorTaha, M.K.
dc.contributor.authorToropainen, M.
dc.contributor.authorTzanakaki, G.
dc.date.accessioned2013-01-28T14:44:24Z
dc.date.available2013-01-28T14:44:24Z
dc.date.issued2012-12
dc.description.abstractNeisseria meningitidis is differentiated into 12 distinct serogroups, of which A, B, C, W-135, X, and Y are medically most important and represent an important health problem in different parts of the world. The epidemiology of N. meningitidis is unpredictable over time and across geographic regions. Recent epidemiological surveillance has indicated an increase of serogoup Y invasive meningococcal disease in some parts of Europe as shown in the epidemiological data for 2010 from various European countries previously published in this journal. ( 1) Here, data are reported indicating that the emergence of serogroup Y continues in 2011 in various regions of Europe. The average age of persons affected by N. meningitidis serogroup Y seems to have decreased in some countries in comparison to the previous decade.por
dc.identifier.citationHum Vaccin Immunother. 2012 Dec;8(12):1907-1911por
dc.identifier.issn2164-5515
dc.identifier.otherdoi:10.4161/hv.21794
dc.identifier.urihttp://hdl.handle.net/10400.18/1177
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherLandes Biosciencepor
dc.relation.publisherversionhttp://www.landesbioscience.com/journals/vaccines/article/21794/?nocache=335932916por
dc.subjectEuropepor
dc.subjectEpidemiologypor
dc.subjectMeningococcal Diseasepor
dc.subjectSerogroup Ypor
dc.subjectSurveillancepor
dc.subjectInfecções Respiratóriaspor
dc.titleMeningococcal serogroup Y emergence in Europe: Update 2011por
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage1911por
oaire.citation.startPage1907por
oaire.citation.titleHuman vaccines and immunotherapeuticspor
oaire.citation.volume8(12)por
rcaap.rightsrestrictedAccesspor
rcaap.typearticlepor

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Meningo Y Europe 2011_inpress2012.pdf
Tamanho:
796.93 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: